Use of Anodal tDCS to Enhance Upper Limb Recovery in Stroke
Launched by TAN TOCK SENG HOSPITAL ·
Trial Information
Current as of September 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a type of gentle brain stimulation, called anodal transcranial direct current stimulation (or tDCS), can help people recover movement in their arms after a stroke. The goal is to see if this treatment, combined with regular rehabilitation, can improve arm strength and function in patients who have had a recent stroke and are experiencing serious weakness in one arm.
The study is looking for about 50 patients who are within 8 weeks of having a stroke and have severe weakness in their upper limb. These patients will be staying at the Tan Tock Seng Hospital stroke rehabilitation wards. If you join the trial, you will be randomly assigned to receive either the real brain stimulation or a “sham” treatment that feels the same but does not deliver the stimulation, so neither you nor the doctors will know which one you get. This helps the researchers fairly compare the effects. The brain stimulation device used has been tested safely in many similar studies before. The trial is currently recruiting participants, and both men and women can take part.
Gender
ALL
Eligibility criteria
About Tan Tock Seng Hospital
Tan Tock Seng Hospital (TTSH) is a leading healthcare institution in Singapore, renowned for its commitment to excellence in patient care, education, and research. As a key player in the clinical research landscape, TTSH actively sponsors and conducts clinical trials across various medical specialties, aiming to advance medical knowledge and improve treatment outcomes. The hospital's robust infrastructure, multidisciplinary expertise, and strong collaborative ties with academic and research institutions enable it to facilitate innovative studies that adhere to the highest ethical and regulatory standards. Through its dedication to clinical research, TTSH strives to contribute significantly to the evolving field of medicine and enhance the health and well-being of the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported